| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.19B | +7.5% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 29.8% | Net margin -12.8% |
| Revenue Q/Q | -11.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.13B | 70.2% |
| R&D | ¥0.01B | 7.6% |
| SG&A | ¥0.06B | 30.1% |
| Tax & other | ¥0.00B | 0.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
康芝药业 ・ ST荃银 ・ 长信科技 ・ *ST金灵 ・ 科新机电 ・ 金刚光伏 ・ 国联水产 ・ 华伍股份 ・ ST易联众 ・ 智云股份 ・ 高新兴 ・ 尤洛卡
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies